Indication
Enterobacter pneumonia
Enterobacter pneumonia is a bacterial lower respiratory tract infection caused by opportunistic, Gram-negative bacilli of the genus *Enterobacter*, most frequently members of the *Enterobacter cloacae* complex. Read more about Enterobacter pneumonia
210 drugs 92 manufacturers
Drugs that treat it
Common Enterobacter pneumonia therapies.
TOBRAMYCIN SULFATE
GENTAMICIN SULFATE
CEFTRIAXONE (ceftriaxone sodium)
CEFTRIAXONE (ceftriaxone sodium)
CIPROFLOXACIN HCL
CEFOTAXIME SODIUM
CLAFORAN (cefotaxime sodium)
CLAFORAN (cefotaxime sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEnterobacter pneumonia is a bacterial lower respiratory tract infection caused by opportunistic, Gram-negative bacilli of the genus *Enterobacter*, most frequently members of the *Enterobacter cloacae* complex.
It primarily manifests as a nosocomial infection—such as hospital-acquired pneumonia or ventilator-associated pneumonia—affecting hospitalized, critically ill, or immunocompromised individuals, as well as elderly patients with structural lung disease.
Pathophysiologically, the condition involves the microaspiration of colonizing oropharyngeal flora or contaminated respiratory equipment into the lower respiratory tract, triggering acute alveolar inflammation and tissue consolidation.
Clinical presentation includes fever, dyspnea, hypoxemia, purulent sputum production, and new pulmonary infiltrates on chest imaging, often complicated by inducible AmpC beta-lactamase production that drives resistance to multiple beta-lactam antimicrobials.
- nih.gov
Enterobacter pneumonia is a bacterial lower respiratory tract infection caused by opportunistic, Gram-negative bacilli of the genus *Enterobacter*, most frequently members of the *Enterobacter cloacae* complex It primarily manifests as a nosocomial infection—such as hospital-acquired pneumonia or ventilator-associated pneumonia—affecting hospitalized, critically ill, or immunocompromised individuals, as well as elderly patients with structural lung disease Pathophysiologically, the condition inv...
- etsu.edu
It primarily manifests as a nosocomial infection—such as hospital-acquired pneumonia or ventilator-associated pneumonia—affecting hospitalized, critically ill, or immunocompromised individuals, as well as elderly patients with structural lung disease
- nih.gov
Pathophysiologically, the condition involves the microaspiration of colonizing oropharyngeal flora or contaminated respiratory equipment into the lower respiratory tract, triggering acute alveolar inflammation and tissue consolidation Clinical presentation includes fever, dyspnea, hypoxemia, purulent sputum production, and new pulmonary infiltrates on chest imaging, often complicated by inducible AmpC beta-lactamase production that drives resistance to multiple beta-lactam antimicrobials
- nih.gov
Pathophysiologically, the condition involves the microaspiration of colonizing oropharyngeal flora or contaminated respiratory equipment into the lower respiratory tract, triggering acute alveolar inflammation and tissue consolidation
- nih.gov
Clinical presentation includes fever, dyspnea, hypoxemia, purulent sputum production, and new pulmonary infiltrates on chest imaging, often complicated by inducible AmpC beta-lactamase production that drives resistance to multiple beta-lactam antimicrobials
- nih.gov
Clinical presentation includes fever, dyspnea, hypoxemia, purulent sputum production, and new pulmonary infiltrates on chest imaging, often complicated by inducible AmpC beta-lactamase production that drives resistance to multiple beta-lactam antimicrobials
Personalize your experience
Follow Enterobacter pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.